IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rand, L. I.
Right arrow Articles by Canner, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rand, L. I.
Right arrow Articles by Canner, P. L.

Investigative Ophthalmology & Visual Science, Vol 26, 983-991, Copyright © 1985 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10

LI Rand, GJ Prud'homme, F Ederer and PL Canner

Natural history data from the Diabetic Retinopathy Study were examined by multivariate methods to determine which baseline characteristics could predict the occurrence of severe visual loss (SVL) in eyes originally assigned to no treatment. The presence and extent of new blood vessels on the optic disc (NVD) had the strongest association with SVL. Several other ocular characteristics also were strongly associated with visual outcome. In the absence of NVD at baseline, the degree of intraretinal hemorrhages and microaneurysms (HMA) had the strongest association with development of SVL. Macular edema was a factor in determining visual loss to 20/200 but not SVL (less than 5/200). Among systemic characteristics, urinary protein was the best predictor of visual outcome, but none were as good as the major ocular variables.


This article has been cited by other articles:


Home page
 Arch OphthalmolHome page
M. S. Roy and J. Skurnick
Six-Year Incidence of Visual Loss in African Americans With Type 1 Diabetes Mellitus: The New Jersey 725
Arch Ophthalmol, August 1, 2007; 125(8): 1061 - 1067.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M El-Bradey, D J Plummer, D Uwe-Bartsch, and W R Freeman
Scanning laser entoptic perimetry for the detection of visual defects associated with diabetic retinopathy
Br. J. Ophthalmol., January 1, 2006; 90(1): 17 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
R. Klein, B. E. K. Klein, S. E. Moss, T. Y. Wong, L. Hubbard, K. J. Cruickshanks, and M. Palta
The Relation of Retinal Vessel Caliber to the Incidence and Progression of Diabetic Retinopathy: XIX: The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Arch Ophthalmol, January 1, 2004; 122(1): 76 - 83.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
F. L. Ferris, M. D. Davis, and L. M. Aiello
Treatment of Diabetic Retinopathy
N. Engl. J. Med., August 26, 1999; 341(9): 667 - 678.
[Full Text] [PDF]

Home page
 NEJMHome page
D. J. D'Amico
Diseases of the Retina
N. Engl. J. Med., July 14, 1994; 331(2): 95 - 106.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the Association for Research in Vision and Ophthalmology